When Pain Speaks for the Mind: Understanding Symptom Expression in Asian Healthcare
Dr. Rudrakshi Shetty, Intern, Nanavati Max Superspeciality Hospital
Keywords: Illness, culture, Asia, somatisation, stigma, mental health, traditional beliefs, religion, family, community, decision-making, cultural syndromes, Taijin Kyofusho, Dhat syndrome, Koro, faith healers, collective care, psychoeducation, ASHA workers, cultural competence, community health, anti-stigma, patient adherence
Illness is rarely a sole component; it is a breakthrough of years of cultural, social, and familial context of an individual’s life. In Asia, where societies are deeply tied by rich traditions, collective identities, and rooted belief systems, culture and community often determine not only what words a patient will use to describe their suffering but also how decisions about treatment are made. Understanding these dynamics in a society is crucial for accurate diagnosis, effective therapy, and ensuring long-term adherence.
One of the most striking cultural influences on healthcare in Asia is the way distress is expressed. Patients frequently describe psychological suffering through bodily symptoms rather than emotions directly. In a selected subset of population alone, the same symptoms maybe be described many different ways. For example, a woman in rural China struggling with depression may fixate on the constant fatigue, dizziness, or stomach pain, while a young man in India with severe anxiety might report “nerve weakness” or palpitations instead of wanting to acknowledge the underlying fear. Medically known as somatisation, is not merely concealment; it reflects socially acceptable phrases of distress in contexts where mental illness carries stigma. Studies from India and China show that over 50% patients later diagnosed with depression or anxiety initially visited general practitioners with physical complaints, leading to under diagnosis of psychiatric conditions.
Beyond somatisation, culture-specific syndromes illustrate how local beliefs shape illness narratives. For instance in Japan, the condition of Taijin Kyofusho involves an intense fear of offending or embarrassing others based on their outward appearance, reflecting societal values and interpersonal sensitivity. In South Asia, Dhat syndrome manifests as anxiety and weakness attributed to semen loss, rooted in historical beliefs about sexual vitality. In Southeast Asia, we see Koro—the sudden fear that the genitals are retracting and may cause death, often spreading as community-wide panics. These syndromes, although puzzling from a Western biomedical perspective, demonstrate how culture frames not only symptoms but also their perceived severity and meaning.
Religion and traditional explanatory models also play a central role. In many South Asian societies, illness may be attributed to fate, karma, or divine punishment. Among certain communities in Indonesia and Malaysia, spirit possession is believed to underlie seizures or hallucinations, which encourages families to seek shamans or religious healers before turning to hospitals. In rural Nepal, some families still consult faith healers for childhood epilepsy, seeing it as a curse rather than a neurological condition. While such pathways can delay biomedical care, they also highlight the importance of integrating traditional belief systems into healthcare strategies. Programs in Sri Lanka and India, for example, have successfully trained religious leaders and traditional healers to recognise symptoms of mental illness and refer patients to clinics, creating a bridge between local worldview and formal medicine.
Stigma remains another powerful determinant of healthcare behaviour in Asia, particularly in mental health. Families often fear that acknowledging a psychiatric diagnosis may bring shame, limit marriage prospects, or expose them to workplace discrimination. In India, a World Health Organisation study reported that over 40 percent of individuals with severe mental illness delayed treatment for more than a year due to stigma. Similar findings have been documented in South Korea and Pakistan, where many patients prefer to label their problems as “stress” or “sleep disturbance” rather than accept psychiatric labels. This stigma operates at both public and personal levels, with many patients internalising negative attitudes, leading to self-stigma that lowers self-esteem and discourages adherence. Encouragingly, community-based campaigns in Thailand and Nepal have demonstrated that involving respected elders, faith leaders, and people with lived experience can shift attitudes, making mental health discussions more acceptable.
Equally significant is the role of family and community in treatment decisions. Unlike Western societies, where individual autonomy is emphasised, decision-making in many Asian cultures is a collective process. In China, South Korea, and much of South Asia, families play a decisive role in whether treatment is accepted, how long it continues, and what type of therapy is chosen. A patient with schizophrenia in India may depend on siblings for financial support, daily supervision, and reminders to take medication, while an elderly patient in Japan may defer completely to the judgment of adult children regarding surgical interventions. This collective framework can provide stability and adherence, but it may also create delays if families reject biomedical explanations in favour of traditional remedies.
Examples from community health programs show how this collective orientation can be harnessed positively. In India’s rural districts, community health workers/ASHA workers have been trained to provide psychoeducation and monitor adherence for patients with depression, often engaging family members directly. In Bangladesh, family-inclusive therapy models for schizophrenia have reduced relapse rates significantly by teaching caregivers about symptom recognition and crisis management. In Cambodia, where war trauma left widespread psychological scars, community-based rehabilitation programs have combined vocational training with counselling, reducing stigma and helping patients reintegrate into society.
The implications for clinicians and policymakers are clear. Effective care in Asia requires cultural competence, not as an optional skill but as a core clinical responsibility. Physicians must ask how patients themselves understand their illness, recognising that symptoms may carry spiritual, moral, or social meanings. Collaboration with traditional healers can shorten delays and build trust, provided such practices do not compromise safety. Most importantly, engaging families as partners rather than passive bystanders ensures treatment decisions are sustainable. Community-level strategies, from anti-stigma education to lay health worker training, are equally critical in regions where formal healthcare infrastructure is limited.
Ultimately, illness in Asia cannot be separated from the cultural and communal web in which it is experienced. Patients may bring their suffering to clinics in the form of bodily pain, may interpret it through the lens of karma or spirits, and may rely on the approval of family elders before accepting therapy. Recognising these realities and accepting is up to clinicians to provide adequate care that is not only medically sound but also culturally resonant. Such an approach is not only respectful of tradition but also essential for better health outcomes across the diverse societies of Asia.
References:
1. Kleinman, A. (2004). Culture and depression. New England Journal of Medicine, 351(10), 951–953.
2. Prakash, O., Kar, S. K., & Singh, A. K. (2015). Dhat syndrome: Evolution of concept, current understanding, and need of an integrated approach. Journal of Human Reproductive Sciences, 8(3), 130–134.
3. World Health Organization (2017). Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: WHO.
